Esperion Therapeutics ESPR Treasury stock, shares (in shares)
Treasury stock, shares (in shares) at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's treasury stock, shares (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's treasury stock, shares (in shares)?
- Esperion Therapeutics (ESPR) reported treasury stock, shares (in shares) of $1.99M in Q1 2026.
- How has Esperion Therapeutics's treasury stock, shares (in shares) changed year-over-year?
- Esperion Therapeutics's treasury stock, shares (in shares) decreased by 0.0% year-over-year, from $1.99M to $1.99M.
- What is the long-term trend for Esperion Therapeutics's treasury stock, shares (in shares)?
- Over 3 years (2022 to 2025), Esperion Therapeutics's treasury stock, shares (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $1.99M to $1.99M.